Open access
Sep 2026
Short-Term Outcomes and Stoma-Related Morbidity of Diverting Ileostomy After Laparoscopic Total Mesorectal Excision Following Neoadjuvant Chemoradiotherapy for Mid- and Distal Rectal Cancer: A Retrospective Single-Center Study
Findings support careful patient selection when balancing the potential benefits of fecal diversion against stoma-related morbidity in DI after laparoscopic total mesorectal excision following neoadjuvant chemoradiotherapy for mid- and distal rectal cancer.
M. Derebey, U. Karabacak, I. Tarim et al.
· Journal of Clinical Medicine · 0 citations